Complement Dependent Cytotoxicity (CDC) Assay

In 1964, Paul Terasaki and John McClelland (Nature 204:998, 1964) introduced the microlymphocytotoxicity test, known as complement dependent cytotoxicity assay or simply CDC, which became the standard serological assay for HLA typing and cross-matching in clinical tissue transplantation.